Q1 Earnings Forecast for Calumet Issued By HC Wainwright

Calumet, Inc. (NASDAQ:CLMT) – Research analysts at HC Wainwright issued their Q1 2026 earnings estimates for Calumet in a note issued to investors on Monday, March 2nd. HC Wainwright analyst A. Dayal forecasts that the oil and gas company will post earnings of ($0.63) per share for the quarter. HC Wainwright currently has a “Buy” rating and a $33.00 price objective on the stock. The consensus estimate for Calumet’s current full-year earnings is ($3.02) per share. HC Wainwright also issued estimates for Calumet’s Q2 2026 earnings at ($0.63) EPS, Q3 2026 earnings at ($0.51) EPS, Q4 2026 earnings at ($0.54) EPS, FY2026 earnings at ($2.32) EPS, FY2027 earnings at ($0.12) EPS and FY2028 earnings at $0.98 EPS.

CLMT has been the subject of several other reports. The Goldman Sachs Group lifted their target price on Calumet from $20.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Zacks Research upgraded Calumet from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 6th. Wall Street Zen cut Calumet from a “buy” rating to a “hold” rating in a report on Sunday, December 14th. UBS Group reaffirmed a “neutral” rating and issued a $26.00 target price on shares of Calumet in a research note on Friday, February 13th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Calumet in a research report on Monday, December 29th. Four research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $22.83.

Calumet Price Performance

CLMT stock opened at $27.89 on Wednesday. The company has a 50 day moving average price of $23.36 and a 200 day moving average price of $20.19. Calumet has a fifty-two week low of $7.68 and a fifty-two week high of $30.35. The stock has a market capitalization of $2.42 billion, a PE ratio of -71.51 and a beta of 1.18.

Calumet (NASDAQ:CLMT) last released its quarterly earnings results on Friday, February 27th. The oil and gas company reported ($0.43) EPS for the quarter, beating the consensus estimate of ($0.67) by $0.24. The company had revenue of ($3,098.50) million for the quarter, compared to the consensus estimate of $1.04 billion. Calumet’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same period last year, the company earned ($0.47) earnings per share.

Hedge Funds Weigh In On Calumet

Several hedge funds have recently added to or reduced their stakes in the stock. Islay Capital Management LLC bought a new position in Calumet during the fourth quarter worth about $25,000. Aster Capital Management DIFC Ltd raised its position in shares of Calumet by 294.7% in the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after acquiring an additional 1,229 shares during the period. Global Retirement Partners LLC bought a new position in Calumet during the 4th quarter worth approximately $34,000. Covestor Ltd boosted its stake in Calumet by 29.1% during the 4th quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock worth $43,000 after acquiring an additional 492 shares during the last quarter. Finally, Amalgamated Bank acquired a new position in Calumet during the second quarter valued at approximately $37,000. Institutional investors and hedge funds own 34.41% of the company’s stock.

Key Headlines Impacting Calumet

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright reaffirmed a “Buy” rating and a $33 price target and projects substantial long‑term profitability (FY2030 EPS forecast of $3.57). That maintained bullish stance and a high target provide a clear upside anchor for the stock.
• Neutral Sentiment: Short‑interest reports show a reported “significant increase” but record zero shares (data appears to be a glitch). Given the inconsistent figures and extremely low days‑to‑cover shown, short interest is unlikely to be a reliable near‑term driver until corrected disclosures appear.
• Negative Sentiment: HC Wainwright lowered near‑term earnings expectations materially: FY2026 EPS was cut to ($2.32) (from ($1.22)), FY2027 to ($0.12) (from $0.23), and FY2028 was trimmed to $0.98 (from $1.35). Quarterly 2026 EPS forecasts are negative across Q1–Q4. These downward revisions signal weaker near‑term profitability and can pressure the stock while investors reassess the recovery timeline.
• Negative Sentiment: An investor (Crossroads Capital) disclosed selling its stake in Calumet, which can create selling pressure or signal reduced conviction by a holder; see the fund’s write‑up for details. Article Title

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.